Factory 99% Lisinopril Powder CAS 83915-83-7 Chemical Intermediate Lisinopril

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A825
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Lisinopril
• CAS: 83915-83-7
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 1g
• Function: Chemical Intermediate
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

 

Product Name	Lisinopril
Appearance	White Powder
CAS NO.	83915-83-7
Storage	Keep in a cool, dry, dark location

 

Lisinopril is an oral medication that belongs to the class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. It is primarily used in the treatment of cardiovascular conditions.

 

1. Hypertension: Lisinopril is widely prescribed for the management of hypertension (high blood pressure), either as monotherapy or in combination with other antihypertensive agents.
2. Heart Failure: It is also indicated in the treatment of heart failure, often in conjunction with diuretics and other cardiac medications, to improve symptoms and reduce the risk of hospitalization.
3. Post-Myocardial Infarction: Following a myocardial infarction (heart attack), lisinopril is used to prevent the recurrence of cardiovascular events by improving cardiac function and reducing blood pressure.

1. ACE Inhibition: Lisinopril inhibits the angiotensin-converting enzyme, which is responsible for converting angiotensin I to angiotensin II. Angiotensin II is a potent vasoconstrictor and a key mediator in the renin-angiotensin-aldosterone system (RAAS).
2. Vasodilation and Blood Pressure Reduction: By inhibiting ACE, lisinopril reduces the formation of angiotensin II, leading to vasodilation and a decrease in peripheral vascular resistance. This results in lower blood pressure and improved blood flow.
3. Cardioprotection: In addition to its blood pressure-lowering effects, lisinopril has been shown to have cardioprotective properties, including reducing left ventricular hypertrophy, improving cardiac function, and decreasing the risk of cardiovascular events.